BioSpace News Archive

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the first quarter ended March 31, 2019, after the market closes on Monday, May 6, 2019.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2019 financial results will be released on Thursday, May 2, after the market closes.

Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced that the U.S. Food and Drug Administration (“FDA”) has approved abbreviated new drug application (“ANDA”) No. 208024 for Fluticasone Propionate Nasal Spray USP,

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced the completion of its acquisition of CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a medical technology company dedicated to non-invasive brain and tissue oxygenation monitoring.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its first quarter 2019 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 2, 2019.

Twenty-nine wounded, ill, and injured post-9/11 service members and veterans visited President Donald Trump at the White House during the annual Washington, DC Wounded Warrior Project® Soldier Ride® – a multi-day cycling event that empowers injured veterans to overcome physical challenges and discover a sense of community among their fellow riders.

Noah Moskin and Maya Grobel share story of infertility in One More Shot documentary

Avalue Technology Inc.(https://www.avalue.com.tw/) (TAIEX: 3479-TW), a global embedded solution provider, associate member of Intel® Internet of Things Solutions Alliance, has recently launched the Avalue E Ink series healthcare solutions

Bioclinica®, a leading provider of science and technology expertise to assist the life science industry in advancing the development of medical therapies, announced today that it has assembled a team of experts dedicated to nonalcoholic fatty liver disease (NAFLD) and its more advanced form, nonalcoholic steatohepatitis (NASH), to help sponsors develop therapeutics using medical imaging and other biomarkers in clinical trials.

Shimmer, a global leader in wearable technology for research applications, today announced the launch of version 2.0 of its NeuroLynQ biometrics neuromarketing platform. NeuroLynQ uses scientifically-validated galvanic skin responses (GSR) to monitor an audience’s nonconscious emotional response to stimuli, such as a live performance or new advertising material.